Histone methylation modification and diabetic kidney disease: Potential molecular mechanisms and therapeutic approaches (Review)
International Journal of Molecular Medicine · 2024
DOI: 10.3892/ijmm.2024.5428 ↗Kurz gefasst
Übersichtsarbeit in der Zeitschrift International Journal of Molecular Medicine, 2024. Verfasst von Peng Qu und 10 weiteren Autor:innen. Beteiligte Einrichtung: Institute of Clinical Medical Sciences, China‑Japan Friendship Hospital, Beijing 100029, P.R. China. Hauptthemen laut MEDLINE: Diabetic Nephropathies, Histones, Epigenesis, Genetic. Die Arbeit wurde bisher 16-mal zitiert (Crossref) und nennt 161 Literaturangaben. Der Volltext ist frei in PubMed Central verfügbar.
Abstract (Originalsprache)
Diabetic kidney disease (DKD) is the leading cause of chronic kidney disease and end‑stage renal disease, and is characterized by persistent proteinuria and decreased glomerular filtration rate. Despite extensive efforts, the increasing incidence highlights the urgent need for more effective treatments. Histone methylation is a crucial epigenetic modification, and its alteration can destabilize chromatin structure, thereby regulating the transcriptional activity of specific genes. Histone methylation serves a substantial role in the onset and progression of various diseases. In patients with DKD, changes in histone methylation are pivotal in mediating the interactions between genetic and environmental factors. Targeting these modifications shows promise in ameliorating renal histological manifestations, tissue fibrosis and proteinuria, and represents a novel therapeutic frontier with the potential to halt DKD progression. The present review focuses on the alterations in histone methylation during the development of DKD, systematically summarizes its impact on various renal parenchymal cells and underscores the potential of targeted histone methylation modifications in improving DKD outcomes.
Schlagwörter
MeSH-Schlagwörter (MEDLINE)
Stichwörter der Autor:innen
Substanzen
Autor:innen und Institutionen
- Institute of Clinical Medical Sciences, China‑Japan Friendship Hospital, Beijing 100029, P.R. China.
- Guang'anmen Hospital, China Academy of Chinese Medical Sciences, Beijing 100029, P.R. China.
- China‑Japan Friendship Hospital, Chinese Academy of Medical Sciences and Peking Union Medical College, Beijing 100029, P.R. China.
- Beijing Key Laboratory of Bioprocess, College of Life Science and Technology, Beijing University of Chemical Technology, Beijing 100029, P.R. China.
- Beijing University of Chinese Medicine Third Affiliated Hospital, Beijing 100029, P.R. China.
Zitieren
APA
Qu, P., Li, L., Jin, Q., Liu, D., Qiao, Y., Zhang, Y., Sun, Q., Ran, S., Li, Z., Liu, T., & Peng, L. (2024). Histone methylation modification and diabetic kidney disease: Potential molecular mechanisms and therapeutic approaches (Review). International Journal of Molecular Medicine. https://doi.org/10.3892/ijmm.2024.5428
Vancouver
Qu P, Li L, Jin Q, Liu D, Qiao Y, Zhang Y, et al. Histone methylation modification and diabetic kidney disease: Potential molecular mechanisms and therapeutic approaches (Review). International Journal of Molecular Medicine. 2024. doi:10.3892/ijmm.2024.5428
BibTeX
@article{Qu2024,
author = {Qu, Peng and Li, Lanfang and Jin, Qi and Liu, Donghai and Qiao, Yuan and Zhang, Yijia and Sun, Qiuyue and Ran, Shuman and Li, Zecheng and Liu, Tongtong and Peng, Liang},
title = {Histone methylation modification and diabetic kidney disease: Potential molecular mechanisms and therapeutic approaches (Review)},
journal = {International Journal of Molecular Medicine},
year = {2024},
doi = {10.3892/ijmm.2024.5428}
}
EUVIMED